<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/623EE08D-4CA8-4337-9D73-292C75362088"><gtr:id>623EE08D-4CA8-4337-9D73-292C75362088</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>PIRBRIGHT LABORATORY ASH ROAD , PIRBRIGHT</gtr:line1><gtr:city>WOKING</gtr:city><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D82F94EC-9E43-4133-AAC5-FB34D0074719"><gtr:id>D82F94EC-9E43-4133-AAC5-FB34D0074719</gtr:id><gtr:name>Government of the UK</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Clinical Veterinary Science</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/623EE08D-4CA8-4337-9D73-292C75362088"><gtr:id>623EE08D-4CA8-4337-9D73-292C75362088</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>PIRBRIGHT LABORATORY ASH ROAD , PIRBRIGHT</gtr:line1><gtr:city>WOKING</gtr:city><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D82F94EC-9E43-4133-AAC5-FB34D0074719"><gtr:id>D82F94EC-9E43-4133-AAC5-FB34D0074719</gtr:id><gtr:name>Government of the UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0729B0AE-F849-430F-A2A1-3A516FA159F1"><gtr:id>0729B0AE-F849-430F-A2A1-3A516FA159F1</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Dick</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/70F3F2E0-6A38-4D92-B823-687F4703E643"><gtr:id>70F3F2E0-6A38-4D92-B823-687F4703E643</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Bailey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/AA26CA9F-524F-40DF-9733-7E0C6FD1CF7B"><gtr:id>AA26CA9F-524F-40DF-9733-7E0C6FD1CF7B</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:surname>Nicholls</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600835"><gtr:id>2105232D-89F3-45CF-B5AB-24C057B8041E</gtr:id><gtr:title>Corneal graft rejection in the inbred minipig</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600835</gtr:grantReference><gtr:abstractText>A corneal transplant (replacing the window of the eye) is often needed to restore sight to a damaged or diseased eye. Sadly about one quarter of transplants are rejected by the white cells of our immune system because they see the transplant as foreign. To learn more about how this happens we need models that closely resemble man. 

Minipigs could be very valuable in two ways. First, they are similar in size to humans. We therefore expect rejection (involving clouding of the cornea) to resemble human rejection very closely. Second, minipigs are partially inbred, which allows investigation of the immune response in ways that are impossible in very genetically diverse human patients.

During the lifetime of the grant we will test how closely rejection in the minipig resembles human rejection and develop methods of measuring immunity that could be used in the clinic to prevent rejection.

If the minipig proves to be a good model, we can later use it to test new treatments, particularly gene therapy. As we are able to keep donor corneas in tissue culture for up to 30 days, genes to combat possible future rejection can be readily introduced into the cornea before the operation.</gtr:abstractText><gtr:technicalSummary>Translation of experimental findings from corneal graft rejection research into genuine improvements for patients is hampered by a lack of in vitro or in vivo models that are accurate clinico-pathological correlates of human rejection. Such models are needed both for studying donor-specific immunity and testing anti-rejection therapies (including gene therapy). The aim is to set up and evaluate such a pre-clinical model in the partially inbred Minnesota minipig.
Key goals are:
1) To perform corneal transplants and characterise rejection clinically and by immunofluorescence histology in recipients of allografts fully mismatched at major histocompatibility complex (MHC) and multiple minor loci.
2) To compare the clinical manifestations of rejection with those in man.
3) To determine the contribution of minor antigens to rejection.
4) To set up assays to monitor T cell immunity that could be implemented clinically. Lymphocyte proliferation assays and ELISpot assays to quantify donor-specific cytokine-producing T cells will be used. Lymphocytes from peripheral blood (the source in patients) will be compared with those from lymphoid organs (the usual source in rodents) as a source of T cells for sensitive immunological monitoring. T cell receptor repertoire in graft, anterior chamber, lymphoid organs and blood will be compared by V-beta-specific spectratyping.
5) To determine whether porcine corneal endothelial cells are mitotic in vivo (as in rats and rabbits) or not (as in man). After rejection or after mechanical removal of corneal endothelial cells we will assess whether residual cells are able to proliferate and restore a functional monolayer.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>300147</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Pirbright Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Babraham pig genome</gtr:description><gtr:id>FAA1C62D-A7C5-4CDC-9325-FAE4B961A0F8</gtr:id><gtr:impact>Tungatt et al, Bringing veterinary immunology up to speed using the Babraham pig model of influenza A infection/ vaccination. European Journal of Immunology</gtr:impact><gtr:partnerContribution>The Pirbright Institute holds the IP on the Babraham pigs and supports the maintenance of the colony. The main colony is currently at APHA in Weybridge. The Pirbright Institute is involved in preliminary genome sequencing studies.
Cardiff University have developed antigen-specific T-cell clones from Babrahams, allowing detailed immunological studies, and have driven sequencing of specific genomic areas. Bath University have been developing approaches to genome editing in the Babrahams.</gtr:partnerContribution><gtr:piContribution>We are now involved in a consortium to develop the highly inbred Babraham line of pigs as a model for pig and human health and disease. My research team has more knowledge of the background of the Babrahams and more expertise in using them than any other in the world. We have used them for transplantation (corneal and laryngeal) and for infectious disease studies (Salmonella and influenza). SNP analysis of Babrahams carried out under this award has pushed development of the necessary genomic tools for CRISPR-Cas9 editing and development of T-cell lines. We are advising on their long-term husbandry and on the strategy for theri development, and collaborating in genome sequencing and influenza studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>SNP analysis of pig genome</gtr:description><gtr:id>E4BCCC9F-6D0F-47D2-B03E-498B74B1D9CD</gtr:id><gtr:impact>1. Identification of genetic locus or loci associated with corneal transplant rejection.
2. Analysis of level of genetic homozygosity within 3 semi-inbred strains of pig. 
Collaboration is between geneticists (Roslin) and immunologists (Bristol) in mucosal, transplant and clinical ocular fields. Manuscript submitted and under review (PlosOne)</gtr:impact><gtr:partnerContribution>SNP analysis of DNA of pig strains used in transplantation studies, statistical analysis and interpretation of data</gtr:partnerContribution><gtr:piContribution>Corneal transplantation and monitoring, harvesting of peripheral blood lymphocytes from pigs, extraction of DNA, assembly of available pig family data, interpretation of data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Government of the UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Animal and Plant Health Agency</gtr:department><gtr:description>Babraham pig genome</gtr:description><gtr:id>92D0CE4C-9310-4CE7-8362-7EED9D374705</gtr:id><gtr:impact>Tungatt et al, Bringing veterinary immunology up to speed using the Babraham pig model of influenza A infection/ vaccination. European Journal of Immunology</gtr:impact><gtr:partnerContribution>The Pirbright Institute holds the IP on the Babraham pigs and supports the maintenance of the colony. The main colony is currently at APHA in Weybridge. The Pirbright Institute is involved in preliminary genome sequencing studies.
Cardiff University have developed antigen-specific T-cell clones from Babrahams, allowing detailed immunological studies, and have driven sequencing of specific genomic areas. Bath University have been developing approaches to genome editing in the Babrahams.</gtr:partnerContribution><gtr:piContribution>We are now involved in a consortium to develop the highly inbred Babraham line of pigs as a model for pig and human health and disease. My research team has more knowledge of the background of the Babrahams and more expertise in using them than any other in the world. We have used them for transplantation (corneal and laryngeal) and for infectious disease studies (Salmonella and influenza). SNP analysis of Babrahams carried out under this award has pushed development of the necessary genomic tools for CRISPR-Cas9 editing and development of T-cell lines. We are advising on their long-term husbandry and on the strategy for theri development, and collaborating in genome sequencing and influenza studies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Bicentenary Celibration, Bristol Eye Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A68A053E-12E8-43E4-B398-6F239D87A344</gtr:id><gtr:impact>Talk raising awareness of outcomes of our MRC-funded research attended by approx. 300 clinicians and other delegates with past and present associations with Bristol Eye Hospital.

none measurable</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in National Eye Research Centre (eye charity) Annual Report</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>754AD7D7-C1BB-4D8C-B6CC-86D523B5DC28</gtr:id><gtr:impact>Annual Report sent to 1500 regular supporters of the charity and published on-line

No measured impact, but clearly raising of public awareness of of research into eye diseases in general and funding by the Medical Research Council for corneal graft rejection research in particular.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A model of human corneal graft rejection in the NIH semi-inbred minipig was set up and evaluated, including ways of habituating pigs to personnel and clinical intervention. The model can be used for testing potential new treatments and is currently being used for basic genetic and immunological studies of clinical relevance.</gtr:description><gtr:id>3715EDCE-1DD1-49C3-8F4C-D298655ADAEF</gtr:id><gtr:impact>1. 3R-associated &amp;quot;Refinement&amp;quot; of animal use:
Development and evaluation of protocols to socialise pigs to research personnel before transplantation to minimise stress of essential peri-operative interventions and to maximise their success (see ref.1)
2. Novel observation that clinically accepted grafts that have never experienced a rejection episode may nevertheless contain cells of the immune system indicative of graft-specific immunity in the recipient (see ref. 2). Further investigation have been hampered by inability to recruit suitably qualified clinical or post-doctoral personnel. 
3. SNP analysis has permitted identification of possible minor histocompatibility loci responsible for immunological rejection. One locus contains the pig homologue of a gene shown previously to mediate rejection in mice, increasing the likelihood that a mismatch at this locus also mediates human corneal graft rejection. 
4. 3R-associated &amp;quot;Reduction&amp;quot; of animal use. SNP typing of potential graft donors and recipients in future will allow prediction of which minipigs will reject corneal grafts with an accuracy of 90% and to select donors and recipients accordingly, thereby reducing the number of animals used, e.g. in a therapeutic trial. 
5. The above capability will also enable early, pre-rejection immunological changes to be studied in relation to the predicted success or failure of a graft.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pig model of corneal graft rejection</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15B6B820-C92F-41AD-A9A9-D390C2B77554"><gtr:id>15B6B820-C92F-41AD-A9A9-D390C2B77554</gtr:id><gtr:title>Perioperative socialization, care and monitoring of National Institutes of Health miniature swine undergoing ocular surgery and sampling of peripheral blood.</gtr:title><gtr:parentPublicationTitle>Laboratory animals</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0315e7074b7db8f73aa544253cd66199"><gtr:id>0315e7074b7db8f73aa544253cd66199</gtr:id><gtr:otherNames>Nicholls SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0023-6772</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1E0B253-6D53-4174-B068-C437074AF906"><gtr:id>A1E0B253-6D53-4174-B068-C437074AF906</gtr:id><gtr:title>Genome-Wide Analysis in Swine Associates Corneal Graft Rejection with Donor-Recipient Mismatches in Three Novel Histocompatibility Regions and One Locus Homologous to the Mouse H-3 Locus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/900f15085684a59c8ecf7e8ff978e3d3"><gtr:id>900f15085684a59c8ecf7e8ff978e3d3</gtr:id><gtr:otherNames>Nicholls S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E73E384D-B813-492A-8594-5AE197D1C2D5"><gtr:id>E73E384D-B813-492A-8594-5AE197D1C2D5</gtr:id><gtr:title>A model of corneal graft rejection in semi-inbred NIH miniature swine: significant T-cell infiltration of clinically accepted allografts.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0315e7074b7db8f73aa544253cd66199"><gtr:id>0315e7074b7db8f73aa544253cd66199</gtr:id><gtr:otherNames>Nicholls SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A27726DC-7AA6-46C8-8B31-F0BD475657A6"><gtr:id>A27726DC-7AA6-46C8-8B31-F0BD475657A6</gtr:id><gtr:title>Bringing veterinary immunology up to speed using the Babraham pig model of influenza A infection/ vaccination</gtr:title><gtr:parentPublicationTitle>EUROPEAN JOURNAL OF IMMUNOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/22a712f6884d72ced1529151a06b4c70"><gtr:id>22a712f6884d72ced1529151a06b4c70</gtr:id><gtr:otherNames>Tungatt K.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600835</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>